About

Immunoinsight Group provides strategic advisory services at the intersection of clinical immunology, biologics development, and investor due diligence. 

​

Nicholas Klaiber M.D.

FAAP, FAAAI, FACAAI

Double board-certified in Allergy and Immunology and Pediatrics, with expertise in immune-mediated disease, translational therapeutics, and clinical program strategy. 

​

Advisory experience spanning: 

• Allergy, asthma and atopic disease biologics

• Immunodeficiency and immune modulation 

• Clinical development strategy 

• Scientific diligence for investors and biotech leadership

• Advising on payer dynamics, access barriers, and real-world reimbursement considerations in immunotherapeutics